Skip to main content
Fig. 6 | Arthritis Research & Therapy

Fig. 6

From: Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy

Fig. 6

DNA methylation downregulated the expression of ACSM5 in a DNMT1-dependent manner. A Pictures showing the morphology of isolated LFCs with 1st and 3rd passage. B Identification of the phenotype of cultured ligamentum flavum (LF) cells using immunofluorescence staining. Immunofluorescence staining for collagen I and Vimentin in cultured cells; n = 3 experiments. C The relative expression level of COL4A3, HSPA6, PIGC, and ACSM5 compared between LFCs from the HLF group and LFCs from the non-HLF group. D The relative DNA methylation level of ACSM5 compared between LFCs from HLF group and LFCs from non-HLF group. E The relative DNA methylation level of ACSM5 in LFCs from HLF patients with the treatment of different concentrations of 5-AzaC. F qPCR and Western Blot results showing the expression level of ACSM5 in LFCs from HLF patients with the treatment of different concentrations of 5-AzaC. G The relative expression level of DNMTs in LFCs from HLF patients with the treatment of indicated DNMT’s shRNA. H qPCR and Western Blot results showing the expression level of ACSM5 in LFCs from HLF patients with the treatment of indicated DNMT’s shRNA. Data were presented as the mean ± SME of three independent experiments. N.S.P > 0.05, #P < 0.05, ##P < 0.01, ###P < 0.001

Back to article page